This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Insmed Inc. It also helps investors analyze the systematic and unsystematic risks associated with investing in Insmed over a specified time horizon. Remember, high Insmed's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Insmed's market risk premium analysis include:
Please note that although Insmed alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., NYSE Composite index.) So in this particular case, Insmed did 0.26 better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Insmed Inc stock's relative risk over its benchmark. Insmed Inc has a beta of 0.51 . As returns on the market increase, Insmed returns are expected to increase less than the market. However, during the bear market, the loss on holding Insmed will be expected to be smaller as well. At this time, Insmed's Book Value per Share is very stable as compared to the past year. As of the 1st of December 2023, Price to Book Value is likely to grow to 33.21, while Enterprise Value over EBITDA is likely to drop (7.81).
Insmed Quarterly Book Value per Share
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Insmed Backtesting, Insmed Valuation, Insmed Correlation, Insmed Hype Analysis, Insmed Volatility, Insmed History and analyze Insmed Performance.
Insmed Market PremiumsInvestors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Insmed market risk premium is the additional return an investor will receive from holding Insmed long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Insmed. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Insmed's performance over market.
Insmed expected buy-and-hold returnsAlthough buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Insmed's Buy-and-hold return. Our buy-and-hold chart shows how Insmed performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.
Insmed Market Price Analysis
Market price analysis indicators help investors to evaluate how Insmed stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Insmed shares will generate the highest return on investment. By understating and applying Insmed stock market price indicators, traders can identify Insmed position entry and exit signals to maximize returns.
Insmed Return and Market MediaThe median price of Insmed for the period between Sat, Sep 2, 2023 and Fri, Dec 1, 2023 is 25.01 with a coefficient of variation of 4.93. The daily time series for the period is distributed with a sample standard deviation of 1.23, arithmetic mean of 24.86, and mean deviation of 0.93. The Stock received substential amount of media coverage during this period.
About Insmed Beta and Alpha
Insmed Upcoming Company Events
As portrayed in its financial statements, the presentation of Insmed's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Insmed's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Insmed's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Insmed. Please utilize our Beneish M Score to check the likelihood of Insmed's management manipulating its earnings.
Build Portfolio with InsmedYour optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.
When determining whether Insmed Inc is a strong investment it is important to analyze Insmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insmed's future performance. For an informed investment choice regarding Insmed Stock, refer to the following important reports:
Build Diversified Portfolios
Align your risk with return expectations
Check out Insmed Backtesting, Insmed Valuation, Insmed Correlation, Insmed Hype Analysis, Insmed Volatility, Insmed History and analyze Insmed Performance.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Insmed Stock analysis
When running Insmed's price analysis, check to measure Insmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insmed is operating at the current time. Most of Insmed's value examination focuses on studying past and present price action to predict the probability of Insmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insmed's price. Additionally, you may evaluate how the addition of Insmed to your portfolios can decrease your overall portfolio volatility.
Insmed technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.